<DOC>
	<DOCNO>NCT00309751</DOCNO>
	<brief_summary>The purpose study compare efficacy safety pitavastatin atorvastatin patient type II diabetes mellitus ( type II DM ) combine dyslipidemia .</brief_summary>
	<brief_title>Study Comparing Pitavastatin Atorvastatin Patients With Type II Diabetes Mellitus Combined Dyslipidemia</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Pitavastatin</mesh_term>
	<criteria>Males female ( age 1875 year ) Type II DM treat oral antidiabetic medication ( sulfonylurea , metformin , glitazones , combination therapy ) Must follow restrictive diet Diagnosis combine dyslipidemia Homozygous familial hypercholesterolemia Conditions may cause secondary dyslipidemia Uncontrolled diabetes mellitus Abnormal pancreatic , liver , renal function Abnormal serum creatine kinase ( CK ) prespecified level Significant heart disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Kowa</keyword>
	<keyword>Type II Diabetes Mellitus</keyword>
	<keyword>Combined Dyslipidemia</keyword>
	<keyword>pitavastatin</keyword>
	<keyword>NK-104</keyword>
	<keyword>Atorvastatin</keyword>
</DOC>